Arthur A. Levin, Director at Avidity Biosciences, Inc. (RNA), sold 1,859 shares at $10.13 ($19K) on 2024-01-22, disclosed to the SEC on 2024-01-23.
Scheduled sale ($19k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RNA | SELL | 2025-08-08 | $5.1M | — | Filing → |
| RNA | SELL | 2025-01-23 | $107K | — | Filing → |
| RNA | SELL | 2024-11-20 | $280K | — | Filing → |